Integrins are important adhesion receptors in all Metazoa that transmit conformational change bidirectionally across the membrane. Integrin a and b subunits form a head and two long legs in the ectodomain and span the membrane. Here, we define with crystal structures the atomic basis for allosteric regulation of the conformation and affinity for ligand of the integrin ectodomain, and how fibrinogen-mimetic therapeutics bind to platelet integrin a IIb b 3 . Allostery in the b 3 I domain alters three metal binding sites, associated loops and a1-and a7-helices. Piston-like displacement of the a7-helix causes a 628 reorientation between the b 3 I and hybrid domains. Transmission through the rigidly connected plexin/semaphorin/integrin (PSI) domain in the upper b 3 leg causes a 70 Å separation between the knees of the a and b legs. Allostery in the head thus disrupts interaction between the legs in a previously described low-affinity bent integrin conformation, and leg extension positions the high-affinity head far above the cell surface.
Integrins are adhesion receptors that transmit signals bidirectionally across the plasma membrane [1] [2] [3] [4] . Rearrangements in integrin extracellular, transmembrane and cytoplasmic domains underlie diverse biological processes, including cell migration, morphogenesis, immune responses and vascular haemostasis. The plateletspecific integrin a IIb b 3 is important in both the arrest of bleeding at sites of vascular injury and pathological thrombosis leading to heart attacks and stroke. Loss of the vascular endothelium results in platelet deposition, and receptors for collagen, thrombin and other agonists then initiate platelet signalling, resulting in changes in the cytoplasmic domains of a IIb b 3 that are transmitted into conformational changes in the extracellular domains. This leads to highaffinity binding of fibrinogen and von Willebrand factor, resulting in crosslinking of platelets into aggregates by these multivalent ligands, and activation by a IIb b 3 of further intracellular signals. Mutations of either a IIb or b 3 result in the bleeding disorder Glanzmann thrombasthenia and drugs that inhibit ligand binding to a IIb b 3 are effective in preventing and treating coronary artery thrombosis 5 . Global structural rearrangements in integrin extracellular domains are demonstrated by electron microscopy and exposure of activation epitopes known as ligand-induced binding sites (LIBS) 2, 4 . Negative stain electron microscopy with image averaging of integrins has demonstrated three overall conformations of the extracellular domain 3, 6 ( Fig. 1a-c) . A low-affinity, bent conformation (Fig. 1a) matches an a V b 3 crystal structure 7, 8 . An extended form with a 'closed' headpiece conformation matching that in the crystal structure represents an intermediate affinity state (Fig. 1b) . Ligand-binding induces a high-affinity, extended form with an 'open' headpiece, in which the angle between the b I and hybrid domains changes from acute to obtuse 3, 6 (Fig. 1c) . This marked change in tertiary structure is supported by mutational studies 3, 6, [9] [10] [11] and solution X-ray scattering 12 . Ligand-mimetic compounds induce the extended, open headpiece conformation of integrins in solution and on the cell surface 3,6,10-13 , and LIBS epitope exposure 14 . In contrast, when a ligand-mimetic is soaked into preformed crystals containing the bent integrin conformation with the closed headpiece, binding induces only localized structural changes near the ligand binding site 8 . In the low-affinity bent structure, the a and b subunit ectodomain carboxy termini 7 and transmembrane domains are closely associated 15, 16 , and transmission of activation signals across the membrane involves separation between the a and b transmembrane and cytoplasmic domains [16] [17] [18] . How allostery could be relayed between the integrin transmembrane domains, legs and ligandbinding head has been unclear. We have proposed that the conformation of the ligand-binding site atop the integrin b I domain could be transmitted to the outward swing of the b hybrid domain between the closed and open headpiece conformations (Fig. 1b, c) by a piston-like b I domain a7-helix motion similar to that seen in integrin a I domains 3, 6 . However, in the absence of atomic views of the high-affinity integrin state, different opinions about its conformation have been put forward.
Here, atomic structures of a IIb b 3 fragments demonstrate the high-affinity, open conformation of the integrin headpiece, its binding to therapeutic antagonists, and the allosteric movements that link the ligand binding site of b I domains to a7-helix displacement and outward swing of the hybrid domain. The b 3 hybrid and PSI domains act as a rigid lever that transmits and amplifies this motion, resulting in a 70 Å separation between the a and b legs at their knees that favours leg extension.
Overall structure of an open integrin headpiece
Two crystal forms each contain a IIb residues 1-452 comprising the b-propeller domain and b 3 residues 1-440 including the b I, hybrid and PSI domains (Fig. 2a, b (Fig. 2a) , and ligand-mimetic antagonist or cacodylate ion bound to the b 3 I domain metal-iondependent adhesion site (MIDAS) (2.7-3.1 Å resolution). Crystal form B contains no Fab and three independent, cacodylate-bound a IIb b 3 molecules per asymmetric unit (2.9 Å resolution). The four independent a IIb b 3 headpiece fragments from the two crystal forms adopt similar conformations, with only minor differences in the angle between the b I and hybrid domains (Fig. 2b) . Five N-linked glycans are resolved, including one in a form A crystal lattice contact with seven carbohydrate residues (Fig. 2a) . Residues 55-77 in our b 3 hybrid domain structures have a different sequence-structure register than previous b 3 structures (Supplementary Material).
Our crystal structures reveal an open, high-affinity conformation of the a IIb b 3 headpiece similar to that in electron microscopy averages of the a V b 3 ectodomain in which ligand binding induced the extended conformation with the open headpiece 3 (Fig. 1c) . Relative to the bent a V b 3 crystal structure with the closed, lowaffinity conformation of the headpiece 3, 7 , the a7-helix of the b 3 I domain moves downward, causing the hybrid and PSI domains to swing away from the a subunit by 628 (Fig. 2d) . The angle between the b I and hybrid domains visualized here is in excellent agreement with that found by electron microscopy for liganded a V b 3 (ref. 3) and the a 5 b 1 headpiece bound to FN3 module 10 of fibronectin 6 ( Fig. 2e) . Ligand-mimetic antagonists are known to induce the conformation of a IIb b 3 with high affinity for fibrinogen 14 . Crystallization in the open conformation may also have been facilitated by truncation of the integrin tailpiece, which participates in extensive interfaces that stabilize the bent a V b 3 conformation 3 . The conformation characterized here termed 'liganded-open' was obtained by co-crystallization with ligand, enabling equilibration to the most favoured ligand-bound conformation before crystallization. By contrast, crystals of a V b 3 were previously formed in the bent, low-affinity conformation which we term 'unliganded-closed', and a ligand-mimetic antagonist was then soaked-in to obtain what we term the 'liganded-closed' conformation 8 . Crystal packing contacts are required for maintenance of the bent, liganded-closed conformation, because in solution addition of the same ligand to bent a V b 3 induces leg extension and conversion of the headpiece to the open conformation 3 . (Fig. 3a) . In macromolecular recognition, the b 3 specificity determining loop (SDL) and four a IIb b-propeller loops that form a cap subdomain are particularly important, with 71% of fibrinogen-sensitive a IIb mutations mapping to the latter 20 . The a IIb -specific 10E5 Fab binds solely to the a IIb cap subdomain (Fig. 2a , Supplementary Material and Supplementary Fig. 2 ) and has no effect on its conformation (Fig. 2b) . Binding of small molecules is not blocked by 10E5, as shown by their co-crystallization (Figs 2a and 3a- Fig. 1a) . Insert 3 forms an a-helix in the a IIb drugbinding pocket (Fig. 3a-d) , and in integrin a subunits that contain I domains forms the ligand-binding a I domain 4 . Inserts 1 and 2 form a four-stranded anti-parallel b-sheet in the centre of the cap subdomain that is buttressed on one side by the a-helix and loop of insert 4, and on the other side by the b 3 SDL (Fig. 2a) . Alternative splicing of cap insert 4 can regulate ligand-binding specificity 22, 23 . The greatest structural differences between the a IIb and a V b-propellers are in cap inserts 1, 2 and 3 (Fig. 2d) . The b 3 SDL closely associates with the cap subdomain, and structural variation between a IIb and a V appears to be responsible for the different b 3 SDL conformations in a IIb b 3 and a V b 3 (Figs 2d and 3d compared with 3f). By contrast, the remainder of the a IIb and a V b-propellers are highly conserved structurally, with a root mean square deviation of 1.4 Å for 391 residues. The hub of the b-propeller that associates with the b I domain is especially conserved, enabling up to eleven diverse integrin a-subunits to bind to a single b-subunit 24 . At their current resolutions of 2.7 Å and 3.1 Å , respectively, there is no significant difference between liganded-open a IIb b 3 and unliganded-closed a V b 3 in orientation between the b-propeller and b I domains (Fig. 2d) .
All crystals reported here were formed in the presence of the physiological cations Ca 2þ and Mg 2þ . Three metal binding sites are present in the b 3 I domain in the drug-binding pocket 8 (Figs 2a and 3a-f). In the middle site, the MIDAS, a Mg 2þ ion coordinates a carboxyl group present in each of the three co-crystallized ligandmimetic a IIb b 3 antagonists (Fig. 3a-d) . The cacodylate ion that is bound to form A (Fig. 3e ) and form B crystals binds in the same way as the carboxyl group of the ligand-mimetics, with one oxygen coordinating the MIDAS Mg 2þ and the other hydrogen-bonding to two backbone amides. The cacodylate may thus act as a pseudoligand, and stabilize the open b subunit I domain conformation similarly to pseudoligand lattice contacts that stabilize the open a subunit I domain conformation [25] [26] [27] . Ca 2þ was assigned at the two sites adjacent to the MIDAS on the basis of Yb 3þ soaking data and coordination chemistry (see Methods). The site distal to the b-propeller is termed adjacent to MIDAS (ADMIDAS). The site near the b-propeller is termed ligand-induced metal binding site (LIMBS). The LIMBS is occupied in the open a IIb b 3 structure even when only a cacodylate pseudoligand is bound (Fig. 3e) .
Two drugs used in prevention and treatment of coronary artery thrombosis, tirofiban and eptifibatide 5 , as well as Merck compound L-739758 (Fig. 3a-d) , antagonize binding of fibrinogen to a IIb b 3 . These compounds were developed as mimics of the Arg-Gly-Asp sequence that is found in a wide variety of integrin glycoprotein ligands, and the a IIb b 3 -binding sequence in fibrinogen, Lys-GlnAla-Gly-Asp-Val 28, 29, 30 . In addition to a IIb b 3 , the integrins 8 , a 5 b 1 and a 8 b 1 recognize the Arg-Gly-Asp motif. Therefore, a major focus of pharmaceutical development was selective inhibition of a IIb b 3 , particularly in comparison to the closely related a V b 3 integrin. Our co-crystal structures (Fig. 3b-d) , and comparison to an a V b 3 -selective compound soaked into a V b 3 crystals (Fig. 3f) 8 , reveal the basis for drug binding and selectivity (see Supplementary Material for details). Each drug has a basic moiety that mimics the arginine in Arg-Gly-Asp or the lysine in the fibrinogen sequence, and a carboxyl group that mimics the aspartic acid. Selectivity for a IIb b 3 and a V b 3 is conferred by a longer and shorter distance, respectively, between the basic and acidic moieties of peptidomimetics (Fig. 3d, f) , which can be adjusted by the constraints on the cyclic ring that bears the basic and aspartic acid residues, and the length of the basic residue side chain 28, 29 . Our structures show that this is because the basic ligand-mimetic side chain must reach further into the deeper b-propeller pocket of a IIb to hydrogen-bond to a IIb -Asp 224 (Fig. 3b-d) , whereas in the a V b-propeller the hydrogen-bonding residues Asp 150 and Asp 218 are nearer in its shallower pocket (Fig. 3f) . Furthermore, Asp 218 in a V is replaced by Phe 231 in a IIb , favouring contacts with longer aliphatic moieties (Fig. 3b-d, f) .
A large number of snake venom disintegrins with Arg-Gly-Asp sequences have evolved to inhibit haemostasis but are not a IIb b 3 -selective. An unusual, a IIb b 3 -selective disintegrin with a Lys-Gly- Asp-Trp sequence led to the development of eptifibatide 31 . The lysine with its longer aliphatic side chain than arginine confers selectivity, whereas the tryptophan confers high affinity. In an independent drug development programme, exosite substituents such as pyridyl sulphonamide were found that substantially increase affinity 30 ( Fig. 3c) and that occupy the same position in the drugbinding pocket as the tryptophan residue (Fig. 3d) .
Comparison to the cacodylate-bound structure (Fig. 3e) (Fig. 4a, e) . A single turn of 3 10 -helix in this loop bearing the key MIDAS and ADMIDAS residue Ser 123 moves en bloc in the liganded-open structure, but the lesser movement in the liganded-closed structure disrupts this 3 10 -helix.
Extensive movements occur in the b6-a7 loop and the a7-helix between the liganded-open and unliganded-closed structures. The b6-a7 loop moves downward, and the a7-helix moves downward and pivots laterally, resulting in an average displacement for residues 333-352 of 5.3 Å (Fig. 4a, c, e) . Between the unligandedclosed and liganded-closed structures there is a movement of lesser magnitude in the b6-a7 loop; however, the movements differ in direction (Fig. 4a, e) . Movement in this region of the ligandedclosed structure is therefore a consequence of strain rather than movement along the pathway towards the open conformation.
In the liganded-open compared with the unliganded-closed structure, the a1-helix moves 32 upward to accommodate movements near its beginning at the MIDAS and ADMIDAS, and near its end, that allow hybrid domain swing-out (Fig. 4a) . Furthermore, a bend between the 3 10 -helix in the b1-a1 loop and the a1-helix is straightened, and the a1-helix is lengthened by five residues, as it pivots laterally to fill-in room vacated by the b6-a7 loop (Fig. 4a, c) . The position of the a1-helix in the liganded-closed structure does not resemble that in the unliganded-closed or the liganded-open structures (Fig. 4a, e) , suggesting that its position is off the pathway towards the open conformation, and results from strain imposed by binding to ligand when the interface with the hybrid domain remains in the closed conformation.
Changes in metal ion coordination are closely related to loop movements in the b I domain, and are key for stabilizing its alternative conformational states (Fig. 4d) . Coordination of the Met 335 backbone carbonyl in the b6-a7 loop to the ADMIDAS Ca 2þ ion in the unliganded-closed conformation (Fig. 4d (Fig. 4d) . Additionally, small shifts in the position of the MIDAS and LIMBS metals relate to marked movements and changes in metal ion coordination of residues Asp 251, Glu 220, Asn 215 and Asp 217 (Fig. 4d) . The metal ions seem to occupy similar but less strained orientations in the liganded-open compared with the liganded-closed structures, with the caveat that the resolutions are 2.7 and 3.3 Å , respectively. For example, the Asp 217 side chain coordinates with the LIMBS metal ion in the liganded-open structure, instead of orienting away from it in the liganded-closed structure 8, 33 (Fig. 4d) . Its position in the liganded-open structure is more consistent with the function of Asp 217 in b7 as a LIMBS residue that stabilizes the high-affinity state 33 . Rearrangements in the b I domain are clearly structurally homologous to those in a I domains (Fig. 4a, b) . Movements of similar directionality occur in the MIDAS metal ion, b1-a1 loop, a1-helix, b6-a7 loop and a7-helix 4 . Hydrophobic ratchet residues that are located one turn of 3 10 -helix apart, stabilize alternative b6-a7 loop positions in both a I and b I domains. In contrast to the one-turn displacement in the intermediate 27 and two-turn displacement in the open a I domain conformations 25, 26 (Fig. 4b) , a oneturn displacement occurs in the open b I domain conformation (Fig. 4a, c) . Val 340, located in an upper hydrophobic pocket in the closed conformation, moves to a lower hydrophobic pocket in the open conformation, displacing Leu 343 (Fig. 4c) . Movement of the a1-helix plays a similar part in activation of a I and b I domains by accompanying the movement of metal-coordinating residues in the b1-a1 loop; however, the greater magnitude of a1-helix movement in the b I domain is accompanied by a unique ratchet-like movement: residue Leu 134 in the a1-helix moves laterally to occupy the upper hydrophobic pocket vacated by Val 340 (Fig. 4b) .
Hybrid domain swing-out
The piston-like displacement of the bI domain a7-helix, which connects to the hybrid domain bC strand, results in complete remodelling of the interface between these domains (Figs 4a and  5a, b; Supplementary Movie 1) . The interface in the closed conformation covers 1,350 Å 2 and includes at its centre hydrogen-bonding residues Tyr 110, Tyr 348 and Arg 352 7 . Upon opening not only does the a7-helix move downward, but the last two residues unwrap from the helix, including Arg 352, which reorients to the exterior of the interface. The more extended conformation at the junction between a7 and bC, and the straightening of the angle between a7 and bC, augment the effect of a7 displacement on hybrid domain swing-out. The more extended, end-to-end orientation between the b I and hybrid domains results in a smaller interface of about 800 Å 2 ( Figs 4a and 5a, b) . Near its centre the interface contains Tyr 110 and Tyr 348, which adopt new hydrogen-bonding partners (Fig. 5b) . Reorganization of hydrogen-bonded interfaces is the general mechanism for allosteric transitions 34 . The smaller size of the open b I/hybrid interface allows some flexibility. Relative to the closed conformation, the hybrid domain swings out 698 in crystal form A, and 578, 598 and 618 in the three molecules in crystal form B (Fig. 2b) .
Structure of an integrin PSI domain
The structure of a PSI domain in an integrin (Fig. 2a and Supplementary Fig. 3b ) and comparison to that in semaphorin 4D 35 demonstrate the predicted homology of these domains in plexins, semaphorins and integrins 36 , and an unexpected insertion. The buried b1 strand bearing the invariant tryptophan, and the disulphide-bonded a1-and a2-helices are well conserved, but other regions differ significantly, including the longer a3-helix (Fig. 5c,  d ). All three shared disulphide bonds superimpose well, and a fourth shared with integrins, plexins and the growth factor receptor MET, but not semaphorins, is also revealed (Fig. 5c, d ). Chemical assignment of disulphides in the integrin b 3 PSI domain was difficult because cysteines are so closely spaced in sequence 37 ; the structural data reassigns all of these disulphides, including the longrange disulphide, which was previously identified as Cys 5 to Cys 435, and is now shown to link Cys 13 to Cys 435 (Fig. 5d, e and Supplementary Fig. 3b) . The long-range disulphide superimposes well with the highly conserved intradomain disulphide that links the second cysteine to the last cysteine in the PSI domain of plexins and semaphorins (Fig. 5c) , and this second cysteine aligns perfectly in all PSI domains, maintaining its relationship to the third cysteine in the conserved a2-helix (Fig. 5d) . These findings suggest that b 3 Cys 435 is the eighth cysteine of the PSI domain, and an integral part of the PSI domain fold. Therefore, there seems to be a nested domain insertion in the b 3 structure: the b I domain is inserted in the hybrid domain, which is in turn inserted in the PSI domain (Fig. 5e) .
Superposition of four independent molecules shows that the 860 Å 2 interface between the hybrid and PSI domain is rigid (Fig. 2c) . Arg 93 of the hybrid domain, which is invariant in vertebrate integrins, inserts its side chain into the centre of the interface, making hydrogen bonds to one hybrid domain residue and three different PSI domain residues (Fig. 5f) . Rigidity of the interface is further supported by the nearby Cys 13-Cys 435, Cys 16-Cys 38 and Cys 26-Cys49 disulphides in the PSI domain, and the Cys 406-Cys 433 disulphide in the hybrid domain (Fig. 5f) . The connection to integrin EGF-like (I-EGF) domain 1 may also be rigid, because a portion of it containing residues 437-440, including Cys 437 that is predicted to be disulphide-linked within I-EGF1 38 , is present in the structure and stabilized by main-chain-side-chain and side-chain-side-chain hydrogen bonds with the PSI domain.
The human platelet alloantigen HPA-1 or Pl A system, of great importance for neonatal alloimmune thrombocytopenia and posttransfusion purpura, corresponds to a leucine/proline polymorphism at PSI residue 33 (ref. 39) . Our structure shows that the Leu 33 side chain is well exposed to solvent (Fig. 2a) on a loop of the PSI domain that is flexible and particularly long in integrins (Fig. 5c, d ). Polymorphic substitution of the distally located residue Arg 93 at the hybrid/PSI interface (Fig. 5f ) disrupts the HPA-1a epitope 40 , demonstrating the importance of the interface for structural integrity of the PSI domain. The I-EGF1 domain also participates in the HPA-1 epitope 41 , further emphasizing the tight linkage between the hybrid, PSI and I-EGF1 domains.
Allosteric mechanism for integrin activation
The structural rearrangements demonstrated here between the closed and open conformations seem to be general for all integrins. The effects of mutations designed to induce hybrid domain swingout 9, 42 ( Fig. 2d) , allosteric activating or inhibitory mAb that bind to the hybrid domain 10, 13 ( Supplementary Fig. 4) , disulphide crosslinks in the b6-a7 loop 43 and shortening of the a7-helix in the b I domain 44 , all support the conclusion that the closed and open conformations of the integrin headpiece have low and high affinity for ligand, respectively. Furthermore, these experiments have been conducted on b 1 , b 2 , b 3 and b 7 integrins, demonstrating the generality of our findings. Moreover, the structural rearrangements shown here are consistent with exposure of LIBS and activation epitopes, including on the PSI domain in models of the complete integrin ectodomain (Supplementary Materials).
Our study reveals the b I/hybrid domain interface as the epicentre for quaternary structural rearrangements in integrins. A movement of about 10 Å occurs at the junction between the b I domain a7-helix and the hybrid domain bC-strand that results in a 628 pivot at the b I/hybrid domain interface. The rigidly connected hybrid and PSI domains act as a mechanical lever in the upper b leg that amplifies and transmits b I domain allostery to the knee between the upper and lower b legs, resulting in a 70 Å displacement at the PSI domain. Because the PSI domain is near the b knee between I-EGF1 and I-EGF2, and in the closed conformation of the headpiece the b knee is near the a subunit knee or genu, the two legs must separate by about 70 Å at their knees (Fig. 1b, c) . Swing-out of the upper b leg could readily occur if it were preceded by extension at the a and b knees (Fig. 1d to 1e to 1g) . Electron microscopy studies show that below the PSI domain, the b leg is flexible in the extended conformation, whereas when the a leg extends, it adopts a single favoured orientation 3 . Interestingly, swing-out of the upper b leg might also occur in the bent conformation (Fig. 1d to 1f) , because if the b subunit upper and lower legs moved as a rigid body, there would be no clash with the a subunit, facilitating conformational equilibration, and despite the 70 Å separation at the knees, the C termini of the a and b subunit ectodomains would only move apart by 15 Å . Thus, adjustments in the flexible b subunit lower leg domains could allow the a and b subunit transmembrane domains to remain associated during upper leg swing-out in the bent conformation (Fig. 1d to 1f to 1g) . Transmembrane domain separation could thus occur as a later event in the process of integrin activation by ligand from outside the cell (Fig. 1g to 1h) , whereas transmembrane domain separation is a key early step in activation by signals from within the cell 3, 16 ( Fig. 1d to 1e to 1j to 1h, or Fig. 1d  to 1i to 1j to 1h) . In the bent a V b 3 integrin conformation, there are large, hydrophilic interfaces of 2,000 Å 2 each between the headpiece and the legs, and between the a and b subunit legs 3 . The latter interface would be disrupted by upper b leg swing-out, thereby weakening that between the headpiece and the legs, and facilitating adoption of the extended integrin conformation with the open headpiece observed for liganded integrins by electron microscopy 3, 6 ( Fig. 1c and 1h) .
Our crystal structures, together with previous structural studies on integrins 3, [6] [7] [8] 12, 15, 38 , now provide a clear picture of the conformational rearrangements in the integrin head that regulate affinity for ligand, and how conformational signals are transmitted to the leg domains. Further structures are needed to define I-EGF domains 1 and 2 in both the bent and extended conformations, the apparently unique conformation of the a subunit genu in the extended conformation 3 , and how allostery is communicated between the b I and a I domains 4 . A
Methods
Protein expression, purification and crystallization , except that a hexahistidine tag was fused to the C terminus of b 3 . The expressed protein was purified by ammonium sulphate precipitation, Ni-NTA affinity chromatography and size exclusion chromatography (Superdex 200 HR), concentrated to 1 mg ml 21 , and treated with chymotrypsin at 25 8C for 16 h. The unclasped (coiled-coil and His 6 tag removed) a IIb b 3 protein was collected in the flow-through of a second Ni-NTA chromatography step. The purified a IIb b 3 was mixed with the 10E5 Fab (1:1.1 molar ratio) and the complex was purified by Superdex 200 chromatography. The complex was subjected to digestion with carboxypeptidase A and B (Calbiochem) (1:100 weight ratio) in the presence of 1 mM ZnCl 2 at 25 8C for 16 h. A stable protease resistant core of a IIb b 3 was obtained and further purified by a final Superdex 200 chromatography step and stored in TBS plus calcium and magnesium, and used to obtain crystal form A. To obtain crystal form B, a IIb b 3 fragment purified through the second Ni-NTA chromatography step was mixed with an excess of the purified fibrinogen g chain C-terminal domain fragment (see Supplementary Information) in the presence of 1 mM MnCl 2 and subjected to carboxypeptidase A and B treatment. This resulted in the same pattern of a IIb b 3 digestion as for the 10E5 Fab complex sample; however, little of the fibrinogen domain co-purified with the a IIb b 3 headpiece upon Superdex 200 chromatography, probably owing to hydrolysis of the a IIb b 3 -binding C-terminal residues of the fibrinogen g chain by carboxypeptidase. This material was used to obtain crystal form B, which contains no fibrinogen fragment.
The Topaz crystallizer (Fluidigm) was used to identify initial crystallization conditions by free interfacial diffusion and the lead conditions were optimized with hanging-drop vapour diffusion. The final optimized well solution for form A crystals of the 10E5 Fab: a IIb b 3 complex is 11% PEG 3350, 0.7 M magnesium acetate and 0.1 M sodium cacodylate, pH 6.5, and for crystal form B is 10% PEG 8000, 0.4 M magnesium acetate and 0.1 M sodium cacodylate, pH 7.0. Acetate and 4 8C temperature were absolutely required for crystallization. To obtain co-crystals with the drugs, protein sample was mixed with each drug at 1:3 to 1:5 molar ratios before setting up the hanging drops. The optimized crystallization conditions were 10-12% PEG 3350, 0.7 M magnesium acetate and 0.1 M imidazole (pH 6.5) in place of cacodylate.
Structure determination
Diffraction data were collected at the 19-ID station of the Advanced Photon Source (APS) at the Argonne National Laboratory and the A-1 station of the Cornell High Energy Synchrotron Source (CHESS). The structure of crystal form A was determined by molecular replacement using search models of the b I domain and the b I domain plus the b-propeller from a V b 3 (PDB ID 1L5G), and a murine Fab 36-71 (PDB ID 6FAB). Electron density maps calculated using phases from the search models clearly showed the presence of the hybrid domain, plus difference densities in the CDR loops of the Fab. The hybrid domain was placed in density and rebuilt. Excellent densities for landmark residues Phe 56, Pro 57, Pro 68 and Leu 69 in the first b-strand of the hybrid domain and multiple nearby disulphide bonds in the hybrid and PSI domains ( Fig. 5f and Supplementary Fig. 3a ) necessitated a change in the sequence-to-structure register of this b-strand. The structure of the PSI domain was built on the basis of the electron density maps computed with refined models and guided by the secondary structure arrangements in the sema4D crystal structure 35 . Strong electron density for the conserved disulphides, the single tryptophan and the secondary structures allowed unambiguous tracing of the whole domain. Continuous electron density extends beyond residue Cys 435 and allowed the building of residues Ala 436 to Gln 440 of I-EGF1, although alternative conformations of these residues cannot be ruled out. The structure of crystal form B was solved by molecular replacement using the a IIb b 3 structure in crystal form A as a search model. The structures of the drug bound a IIb b 3 were solved by molecular replacement using the native structure as a search model. Electron density for the bound drug molecules was readily discernible in the maps calculated with the molecular replacement solution.
